The new long acting muscarinic antagonists for the treatment of COPD; empirical benefits compared with tiotropium.

The new long acting muscarinic antagonists for the treatment of COPD; empirical benefits compared with tiotropium. Order Description The new long acting muscarinic antagonists for the treatment of COPD (chronic obstructive pulmonory disease); empirical benefits compared with tiotropium.